Participants will get updates to optimize care of patients with: Unexplained chronic cough, occupational lung disease, COPD and interventional bronchoscopy, asthma, NSCLC, lung adenocarcinoma and proteogenomics, sleep apnea, GERD in pulmonology, sepsis, ARDS, interstitial lung disease, IPF, hypersensitivity pneumonitis, pneumonia, sarcoidosis, bronchiectasis, cystic fibrosis, pulmonary microbiome, mycobacterial disease, pulmonary hypertension, thromboembolism, lung transplantation, patterns and insights from chest radiology, thoracic ultrasound in critical care, noninvasive respiratory support for acute respiratory failure, novel ventilator modes, palliative care in advanced lung disease.

Special Half-Day Updates:

• Care of COVID-19 and Post-COVID-19 Patients (clinical practices employed at MGH in both inpatient and outpatient settings of responding to the virus, effective infection control measures, clinical trials results)
• Sleep Medicine for the Pulmonologist (including new technologies, reimbursement, telemedicine)

50.75 AMA PRA Category 1 Credits™

Date: April 25-29, 2021